Mestag Therapeutics, a biotech company harnessing new insights into fibroblast-immune interactions, has announced that it has been awarded a “Transforming Cancer Therapeutics” grant from Innovate UK’s Cancer Therapeutics program of 1.5 million GBP (1.9...
Read More
1 Minute
